Prolign Capital makes equity investments in lower middle market companies alongside Independent Sponsors and management teams. Having spent nearly a decade investing in and focusing on this growing asset class, Prolign understands the unique dynamics of successfully aligning with Independent Sponsors and building enterprise value to generate attractive returns.
Prolign Capital, along with its predecessor entity, is one of the preeminent equity partners for the Independent Sponsor community, having invested over $700 million across 40+ Independent Sponsor transactions since 2012.
Over 70 collective years of private equity investing experience with 40 years dedicated to partnering with Independent Sponsors.
People
- Jeff Sangalis, Managing Partner
You last contacted this investor on .